247 related articles for article (PubMed ID: 3600660)
1. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
Olson EN; Spizz G; Tainsky MA
Mol Cell Biol; 1987 Jun; 7(6):2104-11. PubMed ID: 3600660
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
Gossett LA; Zhang W; Olson EN
J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
[TBL] [Abstract][Full Text] [Related]
3. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.
Payne PA; Olson EN; Hsiau P; Roberts R; Perryman MB; Schneider MD
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8956-60. PubMed ID: 3122209
[TBL] [Abstract][Full Text] [Related]
4. Control of myogenic differentiation by cellular oncogenes.
Schneider MD; Olson EN
Mol Neurobiol; 1988; 2(1):1-39. PubMed ID: 3077064
[TBL] [Abstract][Full Text] [Related]
5. A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene.
Sternberg EA; Spizz G; Perry ME; Olson EN
Mol Cell Biol; 1989 Feb; 9(2):594-601. PubMed ID: 2651901
[TBL] [Abstract][Full Text] [Related]
6. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation.
Schneider MD; Perryman MB; Payne PA; Spizz G; Roberts R; Olson EN
Mol Cell Biol; 1987 May; 7(5):1973-7. PubMed ID: 3299056
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.
Vaidya TB; Weyman CM; Teegarden D; Ashendel CL; Taparowsky EJ
J Cell Biol; 1991 Aug; 114(4):809-20. PubMed ID: 1714463
[TBL] [Abstract][Full Text] [Related]
8. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.
Kong Y; Johnson SE; Taparowsky EJ; Konieczny SF
Mol Cell Biol; 1995 Oct; 15(10):5205-13. PubMed ID: 7565669
[TBL] [Abstract][Full Text] [Related]
9. Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. II. Two signaling pathways distinguished by pertussis toxin and a potential role for the ras oncogene.
Kelvin DJ; Simard G; Sue-A-Quan A; Connolly JA
J Cell Biol; 1989 Jan; 108(1):169-76. PubMed ID: 2492022
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
Konieczny SF; Drobes BL; Menke SL; Taparowsky EJ
Oncogene; 1989 Apr; 4(4):473-81. PubMed ID: 2654809
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression.
Spizz G; Hu JS; Olson EN
Dev Biol; 1987 Oct; 123(2):500-7. PubMed ID: 3477514
[TBL] [Abstract][Full Text] [Related]
12. Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways.
Hu JS; Olson EN
J Biol Chem; 1988 Dec; 263(36):19670-7. PubMed ID: 2461941
[TBL] [Abstract][Full Text] [Related]
13. Functional receptors for transforming growth factor-beta are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation.
Hu JS; Olson EN
J Biol Chem; 1990 May; 265(14):7914-9. PubMed ID: 2159464
[TBL] [Abstract][Full Text] [Related]
14. Regulation of myogenic differentiation by type beta transforming growth factor.
Olson EN; Sternberg E; Hu JS; Spizz G; Wilcox C
J Cell Biol; 1986 Nov; 103(5):1799-805. PubMed ID: 3465734
[TBL] [Abstract][Full Text] [Related]
15. Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes.
Olson EN; Capetanaki YG
Oncogene; 1989 Jul; 4(7):907-13. PubMed ID: 2666910
[TBL] [Abstract][Full Text] [Related]
16. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta.
Heino J; Massagué J
J Biol Chem; 1990 Jun; 265(18):10181-4. PubMed ID: 2162338
[TBL] [Abstract][Full Text] [Related]
17. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
Spizz G; Roman D; Strauss A; Olson EN
J Biol Chem; 1986 Jul; 261(20):9483-8. PubMed ID: 3722206
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogenes in the regulatory circuit for myogenesis.
Olson EN
Semin Cell Biol; 1992 Apr; 3(2):127-36. PubMed ID: 1611043
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of fibroblast growth factor on insulin receptor and muscle specific protein gene expression in BC3H-1 myocytes.
Brunetti A; Goldfine ID
Mol Endocrinol; 1990 Jun; 4(6):880-5. PubMed ID: 2172794
[TBL] [Abstract][Full Text] [Related]
20. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes.
Gossett LA; Kelvin DJ; Sternberg EA; Olson EN
Mol Cell Biol; 1989 Nov; 9(11):5022-33. PubMed ID: 2601707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
